Analystreport

Mirum Pharmaceuticals (NASDAQ:MIRM) had its price target raised by analysts at Morgan Stanley from $95.00 to $123.00. They now have an "overweight" rating on the stock.

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report